These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 16759873)
1. C19-steroids as androgen receptor modulators: design, discovery, and structure-activity relationship of new steroidal androgen receptor antagonists. Marwah P; Marwah A; Lardy HA; Miyamoto H; Chang C Bioorg Med Chem; 2006 Sep; 14(17):5933-47. PubMed ID: 16759873 [TBL] [Abstract][Full Text] [Related]
2. Interaction of Androst-5-ene-3β,17β-diol and 5α-androstane-3β,17β-diol with estrogen and androgen receptors: a combined binding and cell study. Chen J; Wang WQ; Lin SX J Steroid Biochem Mol Biol; 2013 Sep; 137():316-21. PubMed ID: 23416106 [TBL] [Abstract][Full Text] [Related]
3. Identification of steroid derivatives that function as potent antiandrogens. Miyamoto H; Marwah P; Marwah A; Yang Z; Chung CY; Altuwaijri S; Chang C; Lardy H Int J Cancer; 2005 Dec; 117(5):866-72. PubMed ID: 15981214 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of SULT2B1b expression alters effects of 3beta-hydroxysteroids on cell proliferation and steroid hormone receptor expression in human LNCaP prostate cancer cells. He D; Falany CN Prostate; 2007 Sep; 67(12):1318-29. PubMed ID: 17626250 [TBL] [Abstract][Full Text] [Related]
5. 5alpha-androstane-3alpha,17beta-diol supports human prostate cancer cell survival and proliferation through androgen receptor-independent signaling pathways: implication of androgen-independent prostate cancer progression. Yang Q; Titus MA; Fung KM; Lin HK J Cell Biochem; 2008 Aug; 104(5):1612-24. PubMed ID: 18320593 [TBL] [Abstract][Full Text] [Related]
6. Suppression of Delta(5)-androstenediol-induced androgen receptor transactivation by selective steroids in human prostate cancer cells. Chang HC; Miyamoto H; Marwah P; Lardy H; Yeh S; Huang KE; Chang C Proc Natl Acad Sci U S A; 1999 Sep; 96(20):11173-7. PubMed ID: 10500149 [TBL] [Abstract][Full Text] [Related]
7. Discovery and structure-activity relationships of new steroidal compounds bearing a carboxy-terminal side chain as androgen receptor pure antagonists. Tachibana K; Imaoka I; Yoshino H; Kato N; Nakamura M; Ohta M; Kawata H; Taniguchi K; Ishikura N; Nagamuta M; Onuma E; Sato H Bioorg Med Chem Lett; 2007 Oct; 17(20):5573-6. PubMed ID: 17804229 [TBL] [Abstract][Full Text] [Related]
8. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells. Zhu ML; Partin JV; Bruckheimer EM; Strup SE; Kyprianou N Prostate; 2008 Feb; 68(3):287-95. PubMed ID: 18163430 [TBL] [Abstract][Full Text] [Related]
9. Delta5-androstenediol is a natural hormone with androgenic activity in human prostate cancer cells. Miyamoto H; Yeh S; Lardy H; Messing E; Chang C Proc Natl Acad Sci U S A; 1998 Sep; 95(19):11083-8. PubMed ID: 9736693 [TBL] [Abstract][Full Text] [Related]
10. Dehydroepiandrosterone upregulates neural androgen receptor level and transcriptional activity. Lu SF; Mo Q; Hu S; Garippa C; Simon NG J Neurobiol; 2003 Nov; 57(2):163-71. PubMed ID: 14556282 [TBL] [Abstract][Full Text] [Related]
11. Proliferative effect of androst-4-ene-3,17-dione and its metabolites in the androgen-sensitive LNCaP cell line. Laplante Y; Poirier D Steroids; 2008 Mar; 73(3):266-71. PubMed ID: 18082864 [TBL] [Abstract][Full Text] [Related]
12. Suppression of androgen receptor expression by dibenzoylmethane as a therapeutic objective in advanced prostate cancer. Jackson KM; Frazier MC; Harris WB Anticancer Res; 2007; 27(3B):1483-8. PubMed ID: 17595765 [TBL] [Abstract][Full Text] [Related]
13. Prosaposin is an AR-target gene and its neurotrophic domain upregulates AR expression and activity in prostate stromal cells. Koochekpour S; Lee TJ; Sun Y; Hu S; Grabowski GA; Liu Z; Garay J J Cell Biochem; 2008 Aug; 104(6):2272-85. PubMed ID: 18481277 [TBL] [Abstract][Full Text] [Related]
14. An AKT activity threshold regulates androgen-dependent and androgen-independent PSA expression in prostate cancer cell lines. Paliouras M; Diamandis EP Biol Chem; 2008 Jun; 389(6):773-80. PubMed ID: 18627304 [TBL] [Abstract][Full Text] [Related]
15. An S296R mutation in the human androgen receptor causes activation of the receptor by non-androgenic steroids and stronger inhibition by the nuclear receptor corepressor N-coR. Li YD; Lu Y; Chen GC; Lu J Clin Exp Pharmacol Physiol; 2008 Oct; 35(10):1252-7. PubMed ID: 18637017 [TBL] [Abstract][Full Text] [Related]
16. Dehydroepiandrosterone and its metabolites: differential effects on androgen receptor trafficking and transcriptional activity. Mo Q; Lu SF; Simon NG J Steroid Biochem Mol Biol; 2006 Apr; 99(1):50-8. PubMed ID: 16524719 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of MAPK-signaling pathway promotes the interaction of the corepressor SMRT with the human androgen receptor and mediates repression of prostate cancer cell growth in the presence of antiandrogens. Eisold M; Asim M; Eskelinen H; Linke T; Baniahmad A J Mol Endocrinol; 2009 May; 42(5):429-35. PubMed ID: 19223455 [TBL] [Abstract][Full Text] [Related]
18. 5alpha-Androstane-3beta,17beta-diol (3beta-diol), an estrogenic metabolite of 5alpha-dihydrotestosterone, is a potent modulator of estrogen receptor ERbeta expression in the ventral prostrate of adult rats. Oliveira AG; Coelho PH; Guedes FD; Mahecha GA; Hess RA; Oliveira CA Steroids; 2007 Dec; 72(14):914-22. PubMed ID: 17854852 [TBL] [Abstract][Full Text] [Related]